// App-Quantinova.ai

: The tyrosine kinase receptor EPHA2 is a drug target for osteoarthritis

Researchers

Presenter

  • M. N. Ferrao Blanco

Principal Investigators

  • Y.M. Bastiaansen-Jenniskens

  • R. Narcisi

  • M.G. Chambers

  • A.A. Pitsillides

  • G.J. van Osch

Medical Centers

  • Erasmus MC, Rotterdam, Netherlands

  • Eli Lilly and Company, Indianapolis, IN

  • The Royal Veterinary College, London, United Kingdom

Locations

  • Netherlands

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Nitric oxide

  • Interleukin 6

  • Matrix metalloproteinase 1

  • Matrix metalloproteinase 13

Drug/Treatment

  • ILS-969

  • Nitric oxide

  • Interleukin

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved